Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: Importance of epitope specificity

Infection and Immunity

Volumn 70, Issue 6, 2002, Pages 2812-2819

  Netski, Dale ^a   Kozel, Thomas R ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL MEMBRANE; CORRELATION ANALYSIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HOST PARASITE INTERACTION; IMMUNE RESPONSE; MOUSE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, FUNGAL; ANTIBODIES, MONOCLONAL; ANTIGENS, FUNGAL; CELLS, CULTURED; CRYPTOCOCCUS NEOFORMANS; EPITOPES, B-LYMPHOCYTE; FEMALE; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MACROPHAGES, PERITONEAL; MICE; PHAGOCYTOSIS; POLYSACCHARIDES; RECEPTORS, IMMUNOLOGIC;

EID: 0036262991     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.6.2812-2819.2002     Document Type: Article

References (39)

1. Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay
2. Capsular polysaccharides of Cryptococcus neoformans
3. Cryptococcus neoformans. II. Phagocytosis by human leukocytes
4. Cryptococcus neoformans. I. Nonencapsulated mutants
5. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan
6. 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network
7. A galactoxylomannan antigen of Cryptococcus neoformans serotype A
8. Polysaccharide antigens of the capsule of Cryptococcus neoformans
9. Cytokine enhancement of complement-dependent phagocytosis by macrophages: Synergy of tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans
10. CR3-dependent phagocytes by murine macrophages: Different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans
11. Interleukin-6 production of human monocytes stimulated with Cryptococcus neoformans components
12. Cryptococcal polysaccharides bind to CD18 on human neutrophils
13. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide
14. Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans
15. Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody
16. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide
17. Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans
18. In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: A critical role for tissue macrophages
19. Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide
20. Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule
21. Benzoquinone activation of Cryptococcus neoformans capsular polysaccharide for construction of an immunoaffinity column
22. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast
23. Influence of opsonization conditions on C3 deposition and phagocyte binding of large and small-capsule Cryptococcus neoformans cells
24. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans
25. Activation and binding of opsonic fragments of C3 on encapsulated Cryprococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins
26. Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide
27. Growth inhibition of Cryptococcus neoformans by cultured human monocytes: Role of the capsule, opsonins, the culture surface, and cytokines
28. Binding of Cryptococcus neoformans by human cultured macrophages: Requirements for multiple complement receptors and actin
29. Biological correlates of capsular (quellung) reactions of Cryptococcus neoformans
30. Protective and non-protective monoclonal antibodies to Cryptococcus neoformans originating from one B-cell
31. Protective murine monoclonal antibodies to Cryptococcus neoformans
32. Spatial and temporal sequence of capsule construction in Cryptococcus neoformans
33. Fc receptors
34. Antibody detection and preparation
35. Toll-like receptor 4 mediates intracellular signaling without TNF-α release in response to Cryptococcus neoformans polysaccharide capsule
36. Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide
37. Immunoglobulin M efficacy against Cryptococcus neoformans: Mechanism, dose dependence, and prozone-like effects in passive protection experiments
38. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes
39. Serologic grouping of Cryptococcus neoformans